| 发明名称 |
USE OF TRANS-PALMITOLEATE IN IDENTIFYING AND TREATING METABOLIC DISEASE |
| 摘要 |
The present invention provides for a novel lipokine, trans-C16:1n7-palmitoleate, which also serves as a biomarker for metabolic status. More specifically, low concentrations of trans-C16:1n7-palmitoleate the serum indicates a risk of metabolic disease. Additionally, administering trans C16:1n7-palmitoleate to a subject (via pharmaceutical, nutraceutical, or other means), positively impacts glucose metabolism. |
| 申请公布号 |
WO2012006612(A2) |
申请公布日期 |
2012.01.12 |
| 申请号 |
WO2011US43517 |
申请日期 |
2011.07.11 |
| 申请人 |
PRESIDENT AND FELLOWS OF HARVARD COLLEGE;MOZAFFARIAN, DARIUSH;CAO, HAIMING;HOTAMISLIGIL, GOKHAN S. |
发明人 |
MOZAFFARIAN, DARIUSH;CAO, HAIMING;HOTAMISLIGIL, GOKHAN S. |
| 分类号 |
A61K31/20;A61K9/08;A61K9/10;A61K31/201;A61P3/00;A61P3/10 |
主分类号 |
A61K31/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
